LEAP2 and obesity disorder: In addition, plasma LEAP2 was found to be positively correlated with some adverse metabolic parameters related to obesity, including BMI, body fat percentage, HOMA-IR, fasting blood glucose and serum triglyceride, VAT volume, and IHCL content [78,79,80].